ES2081407T3 - Composicion farmaceutica en forma de gel en embalaje distribuidor. - Google Patents

Composicion farmaceutica en forma de gel en embalaje distribuidor.

Info

Publication number
ES2081407T3
ES2081407T3 ES91115437T ES91115437T ES2081407T3 ES 2081407 T3 ES2081407 T3 ES 2081407T3 ES 91115437 T ES91115437 T ES 91115437T ES 91115437 T ES91115437 T ES 91115437T ES 2081407 T3 ES2081407 T3 ES 2081407T3
Authority
ES
Spain
Prior art keywords
gel
pharmaceutical composition
distributor
packaging
distributor packaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91115437T
Other languages
English (en)
Inventor
Pierre Tachon
Beatrice Wagneur
Jean-Louis Viret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Application granted granted Critical
Publication of ES2081407T3 publication Critical patent/ES2081407T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • External Artificial Organs (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

SE PREPARA UN PRINCIPIO ACTIVO HABITUALMENTE PRESENTADO EN FORMA DE JARABE, EN UN EXCIPIENTE EN FORMA DE GEL SEUDOPLASTICO QUE SE ACONDICIONA EN EMBALAJE DISTRIBUIDOR CON BOMBA DOSIFICADORA, DE MANERA QUE LA DOSIS TERAPEUTICA SEA LIBERADA EN UNA O DOS PRESIONES SOBRE LA BOMBA POR TOMA TERAPEUTICA. ESTE MODO DE PRESENTACION APORTA LA PRECISION DE DOSIFICACION, LA FACILIDAD Y LA SEGURIDAD DE UTILIZACION EN PARTICULAR EN LOS BEBES, NIÑOS DE PECHO, NIÑOS PEQUEÑOS Y PERSONAS Y LOS ANCIANOS.
ES91115437T 1990-10-04 1991-09-12 Composicion farmaceutica en forma de gel en embalaje distribuidor. Expired - Lifetime ES2081407T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90118920 1990-10-04

Publications (1)

Publication Number Publication Date
ES2081407T3 true ES2081407T3 (es) 1996-03-01

Family

ID=8204572

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91115437T Expired - Lifetime ES2081407T3 (es) 1990-10-04 1991-09-12 Composicion farmaceutica en forma de gel en embalaje distribuidor.

Country Status (27)

Country Link
US (2) US5300302A (es)
EP (1) EP0479005B1 (es)
JP (1) JP3219799B2 (es)
KR (1) KR100213513B1 (es)
AT (1) ATE131039T1 (es)
AU (1) AU643067B2 (es)
BR (1) BR9104280A (es)
CA (1) CA2052615C (es)
DE (1) DE69115210T2 (es)
DK (1) DK0479005T3 (es)
DZ (1) DZ1530A1 (es)
EG (1) EG19906A (es)
ES (1) ES2081407T3 (es)
FI (1) FI104947B (es)
GR (1) GR3018893T3 (es)
HU (1) HU219222B (es)
IE (1) IE72146B1 (es)
IL (1) IL99509A (es)
MA (1) MA22289A1 (es)
MX (1) MX9101391A (es)
MY (1) MY107488A (es)
NO (1) NO303525B1 (es)
NZ (1) NZ240068A (es)
PT (1) PT99143B (es)
RU (1) RU2093143C1 (es)
TN (1) TNSN91085A1 (es)
ZA (1) ZA917627B (es)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
JPH06172189A (ja) * 1992-08-17 1994-06-21 Bristol Myers Squibb Co 胃腸保護複合剤
US5881926A (en) * 1993-03-11 1999-03-16 Taro Pharmaceutical Industries, Ltd. Pharmaceutical compositions in semisolid form and a device for administration thereof
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
WO1996011162A1 (en) * 1994-10-11 1996-04-18 Monson James A Dispensing apparatus for foaming compositions and method
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
CA2262595C (en) * 1996-08-15 2005-10-18 Losan Pharma Gmbh Easy to swallow oral medicament composition
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
US6071523A (en) * 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
US7258869B1 (en) * 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
KR100399483B1 (ko) * 2000-12-12 2003-09-29 대화제약 주식회사 플로로글루시놀을 유효성분으로 함유하는 신규 진경액제
EE200400034A (et) * 2001-06-22 2004-06-15 Pfizer Products Inc. Amorfse ravimaine adsorbaatide farmatseutilised kompositsioonid
JP2004537566A (ja) * 2001-08-01 2004-12-16 ブリストル−マイヤーズ　スクイブ　カンパニー 味マスキング組成物
US7638150B2 (en) * 2002-08-02 2009-12-29 Simply Thick Llp Process for preparing concentrate thickener compositions
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
AU2002356831B2 (en) * 2001-10-22 2006-06-08 Taro Pharmaceutical Industries Ltd. Taste masking spill-resistant formulation
US20050143471A1 (en) * 2001-10-22 2005-06-30 Shen Gao Taste masking spill-resistant formulation
US20030235618A1 (en) * 2001-10-22 2003-12-25 Taro Pharmaceutical Industries Ltd. Taste masking spill-resistant formulation
JP4563679B2 (ja) * 2001-12-06 2010-10-13 デューク ユニバーシティ 形成外科における組織弁壊死の予防
RU2199309C1 (ru) * 2001-12-29 2003-02-27 Закрытое акционерное общество "Брынцалов-А" Лекарственное средство нобрассит седативного и анксиолитического действия
ATE395044T1 (de) 2002-02-01 2008-05-15 Pfizer Prod Inc Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
RU2206322C1 (ru) * 2002-02-18 2003-06-20 Акционерное Курганское общество медицинских препаратов и изделий "Синтез" Лекарственное средство, обладающее болеутоляющим и жаропонижающим действием
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
AU2003238221A1 (en) * 2002-06-17 2003-12-31 Taro Pharmaceuticals U.S.A, Inc. Ibuprofen suspension
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
DE602004019187D1 (de) * 2003-01-31 2009-03-12 Simply Thick Llc Verfahren zur herstellung verbesserter angedickter getränke gegen dysphagie
JP2007501218A (ja) * 2003-08-04 2007-01-25 ファイザー・プロダクツ・インク 非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物
US7201920B2 (en) * 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
EP1744757A4 (en) * 2004-05-04 2009-04-22 Equitech Corp IMPROVED ENHANCED COMPOSITION
PT1765292T (pt) 2004-06-12 2017-12-29 Collegium Pharmaceutical Inc Formulações de fármacos dissuasoras de abuso
RU2276979C2 (ru) * 2004-06-21 2006-05-27 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтический состав антидиарейного действия
EA200701131A1 (ru) * 2004-11-24 2007-12-28 Алгоркс Фармасьютикалз, Инк. Гелеобразная препаративная форма капсаициноида и способы её применения
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US8468029B2 (en) * 2005-11-17 2013-06-18 The Invention Science Fund I, Llc Subscriptions for assistance related to health
US10042980B2 (en) * 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US20070112592A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Payments in providing assistance related to health
US8532938B2 (en) * 2005-11-17 2013-09-10 The Invention Science Fund I, Llc Testing-dependent administration of a nutraceutical
US20070112589A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware User interface for providing assistance related to health
US20070119928A1 (en) * 2005-11-17 2007-05-31 Jung Edward K Generating a nutraceutical request from an inventory
US20080193919A1 (en) * 2005-11-30 2008-08-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems and methods for receiving pathogen related information and responding
US7827042B2 (en) * 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20080082272A1 (en) * 2005-11-30 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US8000981B2 (en) * 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US8297028B2 (en) * 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US20080103746A1 (en) * 2005-11-30 2008-05-01 Searete Llc, A Limited Liability Corporation Systems and methods for pathogen detection and response
US8340944B2 (en) * 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20080004909A1 (en) * 2005-11-30 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems related to nutraceuticals
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US7974856B2 (en) * 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US7927787B2 (en) 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US20070124219A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US20070174128A1 (en) * 2005-11-30 2007-07-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
EP1964040A2 (en) * 2005-12-20 2008-09-03 Searete LLC. Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
MX2008014870A (es) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
US20080086339A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
US20070299695A1 (en) * 2006-06-23 2007-12-27 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
US20080086338A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
EP2049081B1 (en) 2006-08-09 2012-11-14 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
RU2323005C1 (ru) * 2006-12-12 2008-04-27 ООО "РесурсМетод" Способ получения ксантанового загустителя "сараксан" или "сараксан-т"
KR20080076667A (ko) 2007-02-15 2008-08-20 주식회사 중외제약 요변성 약학 조성물
HRP20130259T1 (hr) 2007-04-23 2013-04-30 Intarcia Therapeutics, Inc. Suspenzijske formulacije inzulinotropnih peptida i njihove uporabe
CA2685936C (en) * 2007-05-07 2016-07-12 Clearly Superior, Inc. Food thickening agent, method for producing food thickening agent
US8001345B2 (en) * 2007-05-10 2011-08-16 Dot Hill Systems Corporation Automatic triggering of backing store re-initialization
EP2170283B1 (en) 2007-06-22 2019-01-09 Board of Regents, The University of Texas System Formation of stable submicron peptide or protein particles by thin film freezing
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
EP2376522A4 (en) 2008-11-16 2013-12-25 Univ Texas LOW VISCOSIS HIGHLY CONCENTRATED SUSPENSIONS
US9795617B2 (en) 2009-06-18 2017-10-24 Baucom Institute for Longevity and Life Enhancement, Inc. Hormone delivery system and method
US8658628B2 (en) * 2009-06-18 2014-02-25 Karan Y. Baucom Hormone delivery system and method
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
SMT201700583T1 (it) 2009-09-28 2018-01-11 Intarcia Therapeutics Inc Instaurazione e/o terminazione rapida di erogazione di farmaci in modo sostanzialmente stazionario
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
HUE034955T2 (en) 2010-12-22 2018-03-28 Purdue Pharma Lp Encased tamper resistant controlled release dosage forms
PH12013501345A1 (en) 2010-12-23 2022-10-24 Purdue Pharma Lp Tamper resistant solid oral dosage forms
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
TR201812535T4 (tr) 2011-12-22 2018-09-21 Babolna Bio Ltd Haşere kontrolünde kullanıma yönelik tüketilebilir bir sulu jel, bir sulu jel içeren bir haşere kontrol cihazı ve bir sulu jelin bir haşere kontrol cihazında ve haşereleri kontrol etmeye yönelik bir yöntemde kullanımı.
ES2618204T3 (es) * 2012-10-25 2017-06-21 Nestec S.A. Péptidos amargos encapsulados, métodos para encapsular péptidos amargos y composiciones nutricionales que incluyen péptidos amargos encapsulados
US8550131B1 (en) 2013-01-02 2013-10-08 Liquid Squeeze, LLC Liquid dispensing device, system and method
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US9101156B2 (en) 2013-03-15 2015-08-11 Kent Precision Foods Group, Inc. Thickener composition, thickened nutritive products, methods for preparing thickened nutritive products, and methods for providing nutrition
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
MX389290B (es) * 2015-07-09 2025-03-20 Uniwell Laboratories Llc Composiciones farmacéuticas.
RU2760007C2 (ru) 2016-05-16 2021-11-22 Интарсия Терапьютикс, Инк. Полипептиды, селективные к рецепторам глюкагона, и способы их применения
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法
US11751594B2 (en) 2020-10-22 2023-09-12 Grain Processing Corporation Food thickener composition and method

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767784A (en) * 1970-12-01 1973-10-23 S Gluck Composition for the protection and treatment of injured body tissue and method of utilizing the same
US4155741A (en) * 1974-05-01 1979-05-22 Stauffer Chemical Company Stable suspension system for microencapsulated flowable formulations, and method of preparing stable suspension of microcapsules
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4305933A (en) * 1980-03-10 1981-12-15 Wiczer Sol B Thickened gelatinous edible alcoholic medicated carrier
US4424055A (en) * 1981-12-18 1984-01-03 Herman Wesley K Irrigation and aspiration syringe
EP0084638B1 (de) 1982-01-19 1987-12-23 Gap Gesellschaft Für Auswertungen Und Patente Ag Spender für pastöse Produkte
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
USRE32969E (en) * 1982-10-14 1989-06-27 Injectionable visoelastic ophthalmic gel
US4576645A (en) * 1984-12-06 1986-03-18 Block Drug Co., Inc. Whipped gel composition
IT1183574B (it) * 1985-05-08 1987-10-22 Eurand Spa Metodo per ottenere una sospensione estemporanea omogenea di microcapsule
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
IT1234194B (it) * 1988-05-31 1992-05-06 Magis Farmaceutici Composizioni farmaceutiche in forma di sciroppo contenenti pentitoli quali agenti di veicolazione
US5288479A (en) * 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
US5215739A (en) * 1989-04-05 1993-06-01 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
US4994277A (en) * 1989-10-31 1991-02-19 Pfizer Hospital Products Group, Inc. Use of xanthan gum for preventing adhesions
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package

Also Published As

Publication number Publication date
DK0479005T3 (da) 1996-03-11
CA2052615C (en) 2001-01-16
IL99509A0 (en) 1992-08-18
MY107488A (en) 1995-12-30
PT99143A (pt) 1993-12-31
TNSN91085A1 (fr) 1992-10-25
NO913847D0 (no) 1991-10-01
EG19906A (fr) 1996-05-31
JP3219799B2 (ja) 2001-10-15
KR920007621A (ko) 1992-05-27
IE913286A1 (en) 1992-04-08
IE72146B1 (en) 1997-03-26
DE69115210D1 (de) 1996-01-18
US5300302A (en) 1994-04-05
RU2093143C1 (ru) 1997-10-20
FI914607A0 (fi) 1991-10-01
IL99509A (en) 1995-08-31
ZA917627B (en) 1992-06-24
HU912990D0 (en) 1992-01-28
KR100213513B1 (ko) 1999-08-02
ATE131039T1 (de) 1995-12-15
MX9101391A (es) 1992-04-01
AU643067B2 (en) 1993-11-04
US5505959A (en) 1996-04-09
MA22289A1 (fr) 1992-04-01
EP0479005B1 (fr) 1995-12-06
NO303525B1 (no) 1998-07-27
NZ240068A (en) 1994-05-26
CA2052615A1 (en) 1992-04-05
HUT59587A (en) 1992-06-29
DZ1530A1 (fr) 2002-02-17
DE69115210T2 (de) 1996-05-09
AU8458991A (en) 1992-04-09
PT99143B (pt) 1999-04-30
JPH04247023A (ja) 1992-09-03
GR3018893T3 (en) 1996-05-31
FI104947B (fi) 2000-05-15
HU219222B (en) 2001-03-28
BR9104280A (pt) 1992-06-02
FI914607L (fi) 1992-04-05
NO913847L (no) 1992-04-06
EP0479005A1 (fr) 1992-04-08

Similar Documents

Publication Publication Date Title
ES2081407T3 (es) Composicion farmaceutica en forma de gel en embalaje distribuidor.
DK0383503T3 (da) Udleveringsindretning til oral indgivelse af terapeutiske midler
NO934487D0 (no) Doseringsanordning med forsinket medikamentavgivelse
ATE96308T1 (de) Dosierform fuer verabreichung in der humanmedizin.
NO924209L (no) Doseringsform for tilfoersel av et antiparkinsonmiddel
ES488168A0 (es) Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.
NO920740L (no) Doseringsform for oral administrering av hypoglykemisk glipizid
DK567088D0 (da) Indretning til transdermal laegemiddelindgift
NO912001L (no) Buccal tablett med hurtig utlevering.
DK630188D0 (da) Laegemidler med indhold af azelastin til anvendelse i naesen og/eller i oejet
ATE181670T1 (de) Melatonin enthaltende arzneimittel
ES2075249T3 (es) Dispositivo adhesivo para la administracion transdermica de un agente activo.
DK0705204T3 (da) Poseemballage til flydende lægemidler
AU625402B2 (en) Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances
FI920468A0 (fi) Medicinskt droppglas med kroppsviktsskala.
ES2043567T1 (es) Una composicion farmaceutica de liberacion controlada para uso oral que contiene farmacos anti-inflamatorios no esteroideos.
ES2104491B1 (es) Conjunto de vacunacion contra la enfermedad hemorragica viral del conejo y vacunas acondicionadas para ser utilizadas en dicho conjunto.
Maĭchuk Ocular drug films: problems and perspectives
KR920016104A (ko) 노인성 특발적 백내장 약제 제조를 위한 칼시토닌의 국소적용 용도 및 이의 약제학적 조성물
JPS5935629B2 (ja) 継続投薬用薬剤供給装置
BR9912260A (pt) Emplastro contendo um sistema terapêutico transdérmico e dose única para ministração
ES171385U (es) Vendaje medico.
AR029327A1 (es) Uso de la levobupivacaina para la preparacion de medicamentos de aplicacion en el anestesiamiento de pacientes sujetos a intervencion de cirugia mayor
GR33093B (el) Συσκευη προς χορηγησιν ενεργων ουσιων ιδια αντισυλληπτικων μεσων των γυναικων.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 479005

Country of ref document: ES